Qiagen NV QIA-DE:XETRA

*Data is delayed | EUR
Last | 05/07/21 CEST
39.77quote price arrow up+0.02 (+0.05%)
Volume
452,727
52 week range
36.00 - 46.95

...

Loading . . .
  • Open39.80
  • Day High39.98
  • Day Low39.16
  • Prev Close39.75
  • 52 Week High46.95
  • 52 Week High Date10/13/20
  • 52 Week Low36.00
  • 52 Week Low Date11/09/20

Key Stats

  • Market Cap10,880.94M
  • Shares Out228.41M
  • 10 Day Average Volume471,930.64
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-6.31

KEY STATS

  • Open39.80
  • Day High39.98
  • Day Low39.16
  • Prev Close39.75
  • 52 Week High46.95
  • 52 Week High Date10/13/20
  • 52 Week Low36.00
  • 52 Week Low Date11/09/20
  • Market Cap10,880.94M
  • Shares Out228.41M
  • 10 Day Average Volume471,930.64
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-6.31

RATIOS/PROFITABILITY

  • EPS (TTM)1.63
  • P/E (TTM)24.40
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date01/25/2017
  • Div Amount1.08
  • Split Date-
  • Split Factor-

Profile

MORE
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay...
Thierry Bernard
Chief Executive Officer
Roland Sackers
Chief Financial Officer
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands